Jupiter Neurosciences, Inc. (JUNS)
0.3988
0.00 (0.00%)
USD |
NASDAQ |
Apr 16, 16:00
0.3879
-0.01
(-2.73%)
After-Hours: 20:00
Jupiter Neurosciences Cash from Investing (Quarterly) : 0.00 for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Aethlon Medical, Inc. | -0.0017M |
| Tonix Pharmaceuticals Holding Corp. | -1.019M |
| Phio Pharmaceuticals Corp. | 0.00 |
| Jaguar Health, Inc. | 0.013M |
| MetaVia, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.368M |
| Cash from Financing (Quarterly) | 5.434M |
| Free Cash Flow | -5.414M |
| Free Cash Flow Per Share (Quarterly) | -0.0687 |
| Free Cash Flow to Equity (Quarterly) | -7.498M |
| Free Cash Flow to Firm (Quarterly) | -2.306M |
| Free Cash Flow Yield | -40.29% |